Abbott Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Abbott key operating metrics including Manufacturing Sites (Cardiovascular and Neuromodulation Products), environmental, and social and governance score (ESG).

Manufacturing Sites (Cardiovascular and Neuromodulation Products)

10.7%

FY, 2023

Manufacturing Sites (Nutritional Products)

FY, 2023

Manufacturing Sites (Established Pharmaceutical Products)

FY, 2023

Operating Metrics

Metrics	FY, 2021	FY, 2022	FY, 2023
Manufacturing Sites (Cardiovascular and Neuromodulation Products)	27	28	31
Manufacturing Sites (Nutritional Products)	14	14	14
Manufacturing Sites (Established Pharmaceutical Products)	25	24	24
Manufacturing Sites (Diagnostic Products)	24	22	21
Facility Space, sq. ft.	43M	43M	44M
Remaining Performance Obligations (Medical Devices)	$435.0M	$432.0M	$478.0M
Remaining Performance Obligations (Diagnostic Products)	$4.0B	$4.0B	$4.4B
Reportable Segments	4	4	4

Environmental, Social and Governance (ESG)

Overall

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Learn more

Source:CSRHub

Footer menu

Product

Solutions

Resources

Company

Share price data provided by IEX